Not Tagged
Not Tagged
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)']
today at s annual meeting we will present positive data about our multi-specific #darpin cd3 engager, mp0533. our phase 1 of mp0533 study is on track to be initiated by year-end. read more: #ash22 
World leaders in an entirely new class of custom-built biologic medicines – DARPin® proteins. 
Interests: cool science, solving problems. 
$MOLN